Carotid intima-media thickness and anti-hypertensive treatment: Focus on angiotensin II receptor blockers

C. Cuspidi; C. Sala; M. Tadic; G. Grassi; G. Mancia

doi:10.1016/j.phrs.2018.01.007

Carotid intima-media thickness and anti-hypertensive treatment: Focus on angiotensin II receptor blockers

C. Cuspidi, C. Sala, M. Tadic, G. Grassi, G. Mancia

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	20-26
Number of pages	7
Journal	Pharmacological Research
Volume	129
DOIs	https://doi.org/10.1016/j.phrs.2018.01.007
Publication status	Published - 2018

Keywords

Angiotensin II receptor blockers
Antihypertensive drugs
Carotid intima-media thickness
Ultrasonography
amlodipine
angiotensin receptor antagonist
atenolol
biological marker
candesartan
doxazosin
felodipine
hydrochlorothiazide
irbesartan
losartan
olmesartan
valsartan
antihypertensive therapy
arterial wall thickness
atherosclerosis
cardiovascular mortality
cardiovascular risk
disease association
drug effect
drug efficacy
echography
human
hypertension
morbidity
priority journal
prognosis
Review
risk factor

Cite this

Cuspidi, C., Sala, C., Tadic, M., Grassi, G., & Mancia, G. (2018). Carotid intima-media thickness and anti-hypertensive treatment: Focus on angiotensin II receptor blockers. Pharmacological Research, 129, 20-26. https://doi.org/10.1016/j.phrs.2018.01.007

@article{690999b73d434a81bf8f51c7b9a4433d,

title = "Carotid intima-media thickness and anti-hypertensive treatment: Focus on angiotensin II receptor blockers",

keywords = "Angiotensin II receptor blockers, Antihypertensive drugs, Carotid intima-media thickness, Ultrasonography, amlodipine, angiotensin receptor antagonist, atenolol, biological marker, candesartan, doxazosin, felodipine, hydrochlorothiazide, irbesartan, losartan, olmesartan, valsartan, antihypertensive therapy, arterial wall thickness, atherosclerosis, cardiovascular mortality, cardiovascular risk, disease association, drug effect, drug efficacy, echography, human, hypertension, morbidity, priority journal, prognosis, Review, risk factor",

author = "C. Cuspidi and C. Sala and M. Tadic and G. Grassi and G. Mancia",

note = "Export Date: 11 September 2018 CODEN: PHMRE Correspondence Address: Cuspidi, C.; Istituto Auxologico Italiano, Clinical Research Unit, Viale della Resistenza 23, Italy; email: cesare.cuspidi@unmib.it",

year = "2018",

doi = "10.1016/j.phrs.2018.01.007",

language = "English",

volume = "129",

pages = "20--26",

journal = "Pharmacological Research",

issn = "1043-6618",

publisher = "Academic Press",

}

TY - JOUR

T1 - Carotid intima-media thickness and anti-hypertensive treatment: Focus on angiotensin II receptor blockers

AU - Cuspidi, C.

AU - Sala, C.

AU - Tadic, M.

AU - Grassi, G.

AU - Mancia, G.

N1 - Export Date: 11 September 2018 CODEN: PHMRE Correspondence Address: Cuspidi, C.; Istituto Auxologico Italiano, Clinical Research Unit, Viale della Resistenza 23, Italy; email: cesare.cuspidi@unmib.it

PY - 2018

Y1 - 2018

KW - Angiotensin II receptor blockers

KW - Antihypertensive drugs

KW - Carotid intima-media thickness

KW - Ultrasonography

KW - amlodipine

KW - angiotensin receptor antagonist

KW - atenolol

KW - biological marker

KW - candesartan

KW - doxazosin

KW - felodipine

KW - hydrochlorothiazide

KW - irbesartan

KW - losartan

KW - olmesartan

KW - valsartan

KW - antihypertensive therapy

KW - arterial wall thickness

KW - atherosclerosis

KW - cardiovascular mortality

KW - cardiovascular risk

KW - disease association

KW - drug effect

KW - drug efficacy

KW - echography

KW - human

KW - hypertension

KW - morbidity

KW - priority journal

KW - prognosis

KW - Review

KW - risk factor

U2 - 10.1016/j.phrs.2018.01.007

DO - 10.1016/j.phrs.2018.01.007

M3 - Article

VL - 129

SP - 20

EP - 26

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

ER -

Access to Document

10.1016/j.phrs.2018.01.007

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85040741486&doi=10.1016%2fj.phrs.2018.01.007&partnerID=40&md5=95fa4044614ab660f50485591708c0db